Taking people in BelgiumNo phase
Stores body samples and health data from people with amyloidosis
Collects and stores body samples and clinical data from adults with amyloidosis.
Key facts
- Who runs it
- Universitaire Ziekenhuizen KU Leuven
- Where
- Leuven, BelgiumSee the 2 sites
- Trial code
- Registry title
- BE.Amycon Biobank & Data Registry UZ Leuven
- Status
- Recruiting
- People taking part
- 505 people, planned
- Started
- 24 Sept 2025
- Expected to end
- Jan 2030
- Type of study
- Observational
- Record updated
- 25 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with amyloidosis, suspected or confirmed, of any subtype. They give samples and data for a biobank and a registry.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Amyloidosis, suspected or confirmed, any subtype. For the prospective sample collection only: newly diagnosed (any subtype) or at relapse (AL amyloidosis).
Main reasons for not taking part
- Not willing to sign the informed consent form
- Not able to sign the informed consent form
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Provide consent and sign informed consent form
- Age 18 years or older
- Diagnosis of amyloidosis (suspected or confirmed, any subtypes)
- For the prospective sample collection only: newly diagnosed (any subtype) or at relapse (AL amyloidosis)
Who cannot take part
- Not willing to sign informed consent
- Not able to sign informed consent
Where in Belgium
- UZ Leuven Gasthuisberg - cardiologyLeuven, BelgiumContact: Lucas Van Aelst, Prof.Taking people
- UZ Leuven Gasthuisberg - hematologyLeuven, BelgiumContact: Michel Delforge, Prof.Taking people
About the trial
What the trial wants to find out
The goal of this study is to collect and store human body material (HBM) of patients with amyloidosis in a biobank "BE.Amycon biobank" for future research and to collect clinical data of patients with amyloidosis in a database "BE.Amycon data registry".
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- BE.Amycon Biobank & Data Registry UZ Leuven: Human Body Material (HBM) Collection and Data Collection of Patients With Amyloidosis
- Plain-language title
- Stores body samples and health data from people with amyloidosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 25 September 2026